Post by marriott on Aug 25, 2023 23:34:40 GMT
So on August 22, 2023, Novavax issued a news release stating that " its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies. XBB sublineage variants are overwhelmingly responsible for the majority of current COVID cases in the U.S. and European Union."
Filip Dubovsky is quoted stating " Our data have shown that Novavax's protein-based COVID vaccine induces broadly neutralizing responses against XBB subvariants, including EG.5.1 and XBB.1.16.6." And also stating "we have a lot of confidence in our updated COVID vaccine and are working diligently with global regulatory bodies to ensure our protein-based vaccine is available this fall."
Flu season typically runs from October to May and CDC guidelines generally advise to get your flu vaccine at the end of September, in October or the very first week or so in November.
Now let's look at NVAX share price on the day of the press release through today:
Date .............closed
August 22..........9.16
August 23..........9.01
August 24..........8.23
August 25..........8.05
And yes, I am well aware of the presence and size of share price " short " activities.
The point here is we will continue to experience high volatility in NVAX share price until the road to the marketplace is visible, doable, and in the right direction in the U.S. and European markets!
I always refrain from stating opinions about the future share price. I will say I plan to acquire additional shares through next week ( including Friday).
www.youtube.com/watch?v=eQluGs2SFRs
Filip Dubovsky is quoted stating " Our data have shown that Novavax's protein-based COVID vaccine induces broadly neutralizing responses against XBB subvariants, including EG.5.1 and XBB.1.16.6." And also stating "we have a lot of confidence in our updated COVID vaccine and are working diligently with global regulatory bodies to ensure our protein-based vaccine is available this fall."
Flu season typically runs from October to May and CDC guidelines generally advise to get your flu vaccine at the end of September, in October or the very first week or so in November.
Now let's look at NVAX share price on the day of the press release through today:
Date .............closed
August 22..........9.16
August 23..........9.01
August 24..........8.23
August 25..........8.05
And yes, I am well aware of the presence and size of share price " short " activities.
The point here is we will continue to experience high volatility in NVAX share price until the road to the marketplace is visible, doable, and in the right direction in the U.S. and European markets!
I always refrain from stating opinions about the future share price. I will say I plan to acquire additional shares through next week ( including Friday).
www.youtube.com/watch?v=eQluGs2SFRs